SANDRA ANN contact SPRINGER

Summary

Affiliation: Yale University
Country: USA

Publications

  1. doi request reprint Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community
    Sandra A Springer
    Yale University School of Medicine, Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, 135 College St, Suite 323, New Haven, CT 06510, United States Electronic address
    Contemp Clin Trials 37:209-18. 2014
  2. pmc The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review
    Sandra A Springer
    Yale AIDS Program, Yale University School of Medicine, 135 College Street, Suite 323, New Haven, CT, 06511, USA
    AIDS Behav 16:2119-43. 2012
  3. pmc Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners
    Sandra A Springer
    Section of Infectious Disease, AIDS Program, Yale University School of Medicine, New Haven, Connecticut, United States of America
    PLoS ONE 7:e38335. 2012
  4. pmc Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment
    SANDRA ANN SPRINGER
    Yale AIDS Program, 135 College Street, Suite 323, New Haven, CT 06510, USA
    J Urban Health 87:592-602. 2010
  5. pmc Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy
    Sandra A Springer
    Yale School of Medicine, Yale University AIDS Program, New Haven, CT, USA
    AIDS Care 21:976-83. 2009
  6. pmc Public health implications for adequate transitional care for HIV-infected prisoners: five essential components
    Sandra A Springer
    AIDS Program, Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut 06511, USA
    Clin Infect Dis 53:469-79. 2011
  7. pmc Antiretroviral treatment regimen outcomes among HIV-infected prisoners
    Sandra A Springer
    Yale University AIDS Program, New Haven, CT 06510 2283, USA
    HIV Clin Trials 8:205-12. 2007
  8. ncbi request reprint Managing HIV/AIDS in correctional settings
    Sandra A Springer
    Yale University School of Medicine, Yale AIDS Program, Section of Infectious Diseases, 135 College Street, Suite 323, New Haven, CT 06510, USA
    Curr HIV/AIDS Rep 2:165-70. 2005
  9. pmc Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial
    Duncan Smith Rohrberg Maru
    Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT, USA
    J Acquir Immune Defic Syndr 50:176-81. 2009
  10. pmc Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial
    Frederick L Altice
    Yale University AIDS Program, Yale University, New Haven, CT 06510 2283, USA
    Clin Infect Dis 45:770-8. 2007

Research Grants

  1. Alcohol Pharmacotherapies Among Released Prisoners
    SANDRA ANN contact SPRINGER; Fiscal Year: 2010
  2. Opiate Dependence, HIV and Adherence Interventions
    Sandra Springer; Fiscal Year: 2007
  3. Alcohol Pharmacotherapies Among Released Prisoners
    Sandra Springer; Fiscal Year: 2009
  4. Alcohol Pharmacotherapies Among Released Prisoners
    SANDRA ANN contact SPRINGER; Fiscal Year: 2010
  5. Naltrexone for Opioid Dependent Released HIV+ Criminal Justice Populations
    SANDRA ANN contact SPRINGER; Fiscal Year: 2010

Detail Information

Publications17

  1. doi request reprint Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community
    Sandra A Springer
    Yale University School of Medicine, Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, 135 College St, Suite 323, New Haven, CT 06510, United States Electronic address
    Contemp Clin Trials 37:209-18. 2014
    ..Extended-release naltrexone (XR-NTX) effectively reduces relapse to alcohol in alcohol dependent persons, yet it remains unexamined among criminal justice system (CJS) populations transitioning to the community...
  2. pmc The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review
    Sandra A Springer
    Yale AIDS Program, Yale University School of Medicine, 135 College Street, Suite 323, New Haven, CT, 06511, USA
    AIDS Behav 16:2119-43. 2012
    ..More research specifically addressing the impact of other mental disorders besides depression on cART adherence and RCTs evaluating ADT on cART adherence are also needed...
  3. pmc Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners
    Sandra A Springer
    Section of Infectious Disease, AIDS Program, Yale University School of Medicine, New Haven, Connecticut, United States of America
    PLoS ONE 7:e38335. 2012
    ..This prospective study evaluates the use of buprenorphine/naloxone (BPN/NLX) as a method to reduce relapse to opioid use and sustain viral suppression among released HIV-infected prisoners meeting criteria for opioid dependence (OD)...
  4. pmc Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment
    SANDRA ANN SPRINGER
    Yale AIDS Program, 135 College Street, Suite 323, New Haven, CT 06510, USA
    J Urban Health 87:592-602. 2010
    ..Future randomized controlled trials are needed to affirm its benefit in this highly vulnerable population...
  5. pmc Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy
    Sandra A Springer
    Yale School of Medicine, Yale University AIDS Program, New Haven, CT, USA
    AIDS Care 21:976-83. 2009
    ..Factors associated with changes in depressive symptoms among this group receiving antiretroviral treatment that have not been extensively evaluated...
  6. pmc Public health implications for adequate transitional care for HIV-infected prisoners: five essential components
    Sandra A Springer
    AIDS Program, Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut 06511, USA
    Clin Infect Dis 53:469-79. 2011
    ....
  7. pmc Antiretroviral treatment regimen outcomes among HIV-infected prisoners
    Sandra A Springer
    Yale University AIDS Program, New Haven, CT 06510 2283, USA
    HIV Clin Trials 8:205-12. 2007
    ..Despite the high prevalence of HIV in correctional settings, the duration of therapy and response to various highly active antiretroviral therapy (HAART) regimens in this setting is unknown...
  8. ncbi request reprint Managing HIV/AIDS in correctional settings
    Sandra A Springer
    Yale University School of Medicine, Yale AIDS Program, Section of Infectious Diseases, 135 College Street, Suite 323, New Haven, CT 06510, USA
    Curr HIV/AIDS Rep 2:165-70. 2005
    ....
  9. pmc Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial
    Duncan Smith Rohrberg Maru
    Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT, USA
    J Acquir Immune Defic Syndr 50:176-81. 2009
    ....
  10. pmc Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial
    Frederick L Altice
    Yale University AIDS Program, Yale University, New Haven, CT 06510 2283, USA
    Clin Infect Dis 45:770-8. 2007
    ..Directly administered antiretroviral therapy (DAART) is one approach to improve treatment adherence among human immunodeficiency virus (HIV)-infected drug users...
  11. ncbi request reprint Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community
    Sandra A Springer
    Yale AIDS Program, Yale University School of Medicine, New Haven, Connecticut 06510 2283, USA
    Clin Infect Dis 38:1754-60. 2004
    ..More effective community-release programs are needed for incarcerated patients with HIV disease...
  12. pmc Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy
    Duncan Smith Rohrberg Maru
    Yale University AIDS Program, 135 College Street, Suite 323, New Haven, CT 06510 2283, USA
    AIDS Behav 12:284-93. 2008
    ..The presence of depression and the lack of willingness to travel greater than four blocks to receive DAART predicted time-to-discontinuation...
  13. pmc Correlates of HIV infection among incarcerated women: implications for improving detection of HIV infection
    Frederick L Altice
    Yale University, School of Medecine, New Haven, CT 06510 2283, USA
    J Urban Health 82:312-26. 2005
    ..Alternative methods of facilitating more widespread HIV testing, such as saliva tests, rapid serologic tests, and more routine testing in high HIV-prevalence areas should be considered both for clinical and for public health benefits...
  14. ncbi request reprint Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication
    Frederick L Altice
    Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut 06510 2283, USA
    Clin Infect Dis 38:S376-87. 2004
    ..Moreover, DAART should incorporate enhanced elements such as convenience, flexibility, confidentiality, cues and reminders, responsive pharmacy and medical services, and specialized training for staff...
  15. pmc Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial
    Duncan Smith Rohrberg Maru
    Yale University AIDS Program, Yale University School of Medicine, New Haven, CT 06510 2283, USA
    J Acquir Immune Defic Syndr 46:555-63. 2007
    ..Directly administered antiretroviral therapy (DAART) is an effective intervention that improves clinical outcomes among HIV-infected drug users. Its effects on antiretroviral drug resistance, however, are unknown...
  16. ncbi request reprint Human immunodeficiency virus infection with human granulocytic ehrlichiosis complicated by symptomatic lactic acidosis
    Sandra A Springer
    Yale University AIDS Program, Yale New Haven Hospital and Yale School of Medicine, New Haven, CT, 06510 2283, USA
    Clin Infect Dis 36:e162-4. 2003
    ..To date, this is the first presentation of symptomatic hyperlactatemia in a patient with HIV infection and HGE...
  17. pmc A pilot survey of attitudes and knowledge about opioid substitution therapy for HIV-infected prisoners
    Sandra A Springer
    Yale School of Medicine, New Haven, CT, USA
    J Opioid Manag 4:81-6. 2008
    ..This study found that more education of individuals treating and caring for HIV-infected opioid dependent prisoners is needed...

Research Grants6

  1. Alcohol Pharmacotherapies Among Released Prisoners
    SANDRA ANN contact SPRINGER; Fiscal Year: 2010
    ....
  2. Opiate Dependence, HIV and Adherence Interventions
    Sandra Springer; Fiscal Year: 2007
    ..Her work will contribute greatly to the interface between HIV and substance abuse treatment where rigorously evaluated interventions are needed. ..
  3. Alcohol Pharmacotherapies Among Released Prisoners
    Sandra Springer; Fiscal Year: 2009
    ....
  4. Alcohol Pharmacotherapies Among Released Prisoners
    SANDRA ANN contact SPRINGER; Fiscal Year: 2010
    ....
  5. Naltrexone for Opioid Dependent Released HIV+ Criminal Justice Populations
    SANDRA ANN contact SPRINGER; Fiscal Year: 2010
    ....